[PDF] Top 20 Análisis de políticas monetarias: expansión cuantitativa
Has 10000 "Análisis de políticas monetarias: expansión cuantitativa" found on our website. Below are the top 20 most common "Análisis de políticas monetarias: expansión cuantitativa".
Raltegravir in the management of HIV-infected patients
... of patients in the BENCHMRK trials with virological failure on raltegravir, in whom genotyping was performed, exhibited mutations in integrase known to be associated with raltegravir resistance ... See full document
7
Role of raltegravir in the management of HIV-1 infection
... of raltegravir in combination with optimized background regimens (OBT) in HIV-infected patients with multidrug-resistant ...virus. Patients enrolled in the study were required to be ... See full document
5
Management of <em>Pneumocystis Jirovecii</em> pneumonia in HIV infected patients: current options, challenges and future directions
... Side effects occur in up to 50% of patients receiving pent- amidine. These reactions have conveniently been categorized as immediate, local, and systemic and have also included deaths. Immediate reactions include ... See full document
5
Long-term efficacy and safety of raltegravir in the management of HIV infection
... time patients were allowed to continue or join in an open-label extension with RAL 400 mg twice daily for a total of 96 ...RAL patients continued into the open-label portion of the trial; 86 patients ... See full document
16
New and emerging agents in the management of lipodystrophy in HIV-infected patients
... in patients with lipodsytrophy, changes in limb fat between weeks 0 and 48 were measured using ...Among patients not receiving stavudine (n = 48 vs 46), the increase was ... See full document
10
Management of chronic diarrhea in HIV-infected patients: current treatment options, challenges and future directions
... of HIV infection regardless of whether the patients have AIDS. HIV and malnutrition tend to occur in the same populations, the underprivileged and ...in HIV-infected patients, ... See full document
6
Periodontal Management of HIV-infected Patients : An Overview
... of HIV disease, at least in the industrialized world, into a manageable chronic ...of HIV RNA and extends AIDS- free survival, at least in the ...Moreover, HIV suppression with antiretroviral therapy ... See full document
6
Emerging role of integrase inhibitors in the management of treatment-experienced patients with HIV infection
... isoenzymes. Raltegravir is 83% bound to human proteins in ...for HIV-1 in 50% normal serum) in all treatment groups tested, thus confi rming the twice daily dosing schedule that has been approved for ... See full document
40
Changes in Bone Mineral Density through 96 Weeks in Antiretroviral Naïve HIV 1 Infected Patients Receiving Abacavir/Lamivudine and Raltegravir in the SHIELD Trial
... RAL patients. In the KITE study, virologically suppressed HIV-infected patients who were switched from standard highly active ART to a nu- cleoside reverse transcriptase inhibitor (NRTI) ... See full document
10
Immune reconstitution inflammatory syndrome in HIV-infected patients
... Key knowledge gaps in the diagnosis and treatment of IRIS exist. There are no standardized clinical case defini- tions for many forms of IRIS (TB-IRIS and C-IRIS being the exceptions). Confirmatory diagnostic tests are ... See full document
10
Combination dolutegravir–abacavir–lamivudine in the management of HIV/AIDS: clinical utility and patient considerations
... in HIV type 1 (HIV-1) ...of HIV-1-infected adult patients, with distinct advantages compared with other available antiretroviral ...as raltegravir-, darunavir/ritonavir-, and ... See full document
8
Profile of darunavir in the management of treatment-experienced HIV patients
... for HIV-infected person in all states of ...recently. Raltegravir, the first HIV integrase inhibitor, seems to work well with ...the patients received DRV/r as part of their optimized ... See full document
5
Extended use of raltegravir in the treatment of HIV-1 infection: optimizing therapy
... Abstract: Raltegravir is the first licensed compound in 2007 of the new integrase inhibitor drug ...daily, raltegravir showed a potent antiviral action in antiretroviral-naïve patients when ... See full document
12
Clinical, virological and immunological responses in Danish HIV patients receiving raltegravir as part of a salvage regimen
... cohort patients: From DHCS we identified a control cohort of HIV-infected patients who started HAART for the first time after 1 January 2006 and before 1 July ...control patients for ... See full document
8
Ocular surface squamous neoplasia in HIV-infected patients: current perspectives
... with HIV infection, focusing mainly on the epidemiology, pathophysiology, clinical manifestations, diagnosis, and treatment of these tumors in patients with ...the HIV pandemic most severely affected ... See full document
14
Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial
... ment-experienced HIV-infected patients. A total of 169 patients were enrolled in the study, results have been pre- viously published and showed the non-inferiority of RAL vs ENF [9, ... See full document
7
Role of etravirine in the management of treatment-experienced patients with human immunodeficiency virus type 1
... Etravirine, a second-generation NNRTI, received FDA approval in January 2008 for the management of treatment-experienced, HIV-infected adults with NNRTI- resistant viruses. It has a high genetic ... See full document
6
Raltegravir: The evidence of its therapeutic value in HIV-1 infection
... to raltegravir, while the sensitivity of E92Q and G140S/Q148H mutants was reduced by 7- to ...with raltegravir seems to be increased in patients with a higher baseline HIV-1 RNA levels and ... See full document
15
Raltegravir for HIV-1 infected children and adolescents: efficacy, safety, and pharmacokinetics
... between raltegravir and dolutegravir. While raltegravir has a low genetic barrier to resis- tance, this effect has not been noted in pediatric ...of raltegravir acting as monotherapy and thereby ... See full document
22
Raltegravir in treatment naïve patients
... and patients starting antiretroviral treatment during acute or recent infection have significantly smaller amount of viral DNA after 36 weeks of treatment than patients start- ing HAART during chronic ... See full document
11
Related subjects